The Effect of Reiki on Hopelessness Level
1 other identifier
interventional
32
1 country
1
Brief Summary
This quasi-experimental study aims to examine the effect of Reiki on the level of hopelessness in oncology patients. The study was conducted at İzmir Tepecik Training and Research Hospital with 32 patients in both experimental and control groups. Patients performed Reiki daily for a week following each chemotherapy session for 4 cycles. Data were collected using the "Individual Information Form" and the "Beck Hopelessness Scale" through face-to-face and telephone interviews. Ethical approval was obtained, and data were analyzed using SPSS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedFirst Submitted
Initial submission to the registry
April 7, 2025
CompletedFirst Posted
Study publicly available on registry
May 1, 2025
CompletedMay 1, 2025
April 1, 2025
2 years
April 7, 2025
April 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The research data will be collected using the "Individual Information Form" and the "Beck Hopelessness Scale" prepared by the researchers in line with the literature.
Individual Information Form: The form prepared by the researchers consists of 14 questions. Beck Hopelessness Scale: The Beck Hopelessness Scale was developed by Beck and colleagues in 1974 to determine the degree of pessimism an individual has about the future. The scale consists of 20 items in a five-point Likert format. The questions are answered as true or false and reflect negative expectations. Each answer that matches the given key scores 1 point, while answers that do not match score 0 points. The total score obtained is considered the "hopelessness" score, with higher scores indicating higher levels of hopelessness. The scale's score range is 0-20. The questions on the scale cover emotional, motivational, and cognitive dimensions. The scale consists of three factors: "Feelings about the Future," "Loss of Motivation," and "Future Expectations" (Durak \& Palabıyıkoğlu, 1994). In this study, the Cronbach's Alpha value for hopelessness was calculated as 0.952.
The research data were collected through face-to-face and telephone interviews after obtaining ethical committee approval. The time required for individuals to complete the forms is approximately 10 minutes.
Study Arms (2)
Reiki Group
EXPERIMENTALPatients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week.
control group
NO INTERVENTIONOnly data collection forms were filled in the control group. No intervention was made.
Interventions
Patients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Science University
Istanbul, 34668, Turkey (Türkiye)
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
Gamze TEMİZ, Dr
Saglik Bilimleri Universitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2025
First Posted
May 1, 2025
Study Start
April 1, 2023
Primary Completion
March 31, 2025
Study Completion
March 31, 2025
Last Updated
May 1, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share